Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Alpha Teknova
TKNO
$382M
| $6.38M | ﹤0.01% |
256,344
+52,075
| +25% | +$1.11M |
|
2552
Ziff Davis
ZD
$1.91B
| $6.38M | ﹤0.01% |
53,698
-102,294
| -66% | -$12.3M |
|
2553
CALL
West Pharmaceutical
WST
$23.7B
| $6.37M | ﹤0.01% |
+15,000
| New | +$6.32M |
|
|
CIM
2554
Chimera Investment
CIM
$963M
| $6.37M | ﹤0.01% |
142,915
+91,875
| +180% | +$4.12M |
|
2555
American States Water
AWR
$3.56B
| $6.36M | ﹤0.01% |
74,403
-133,231
| -64% | -$11.7M |
|
|
PANA
2556
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $6.36M | ﹤0.01% |
651,312
-22,995
| -3% | -$227K |
|
|
FISV
2557
Fiserv Inc
FISV
$28.3B
| $6.36M | ﹤0.01% |
58,631
-250,227
| -81% | -$28M |
|
|
ZFOX
2558
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $6.36M | ﹤0.01% |
636,072
-32,314
| -5% | -$322K |
|
2559
Brookdale Senior Living
BKD
$2.8B
| $6.33M | ﹤0.01% |
1,005,054
-672,062
| -40% | -$4.8M |
|
2560
CALL
Coursera
COUR
$1.71B
| $6.33M | ﹤0.01% |
+200,000
| New | +$7.53M |
|
2561
WIX.com
WIX
$3.67B
| $6.33M | ﹤0.01% |
32,301
-5,596
| -15% | -$1.39M |
|
|
ABGI
2562
DELISTED
ABG Acquisition Corp. I
ABGI
| $6.33M | ﹤0.01% |
649,571
-36,758
| -5% | -$358K |
|
2563
Dorman Products
DORM
$3.84B
| $6.32M | ﹤0.01% |
66,724
+46,577
| +231% | +$4.59M |
|
2564
Nasdaq
NDAQ
$55.5B
| $6.31M | ﹤0.01% |
98,034
+70,917
| +262% | +$4.46M |
|
2565
YPF Sociedad Anonima ADS
YPF
$19.7B
| $6.3M | ﹤0.01% |
1,352,818
+165,379
| +14% | +$773K |
|
2566
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$133M
| $6.3M | ﹤0.01% |
14,153
-9,654
| -41% | -$4.33M |
|
2567
GoDaddy
GDDY
$12.4B
| $6.3M | ﹤0.01% |
90,379
-228,932
| -72% | -$17.7M |
|
2568
PUT
General Dynamics
GD
$103B
| $6.29M | ﹤0.01% |
32,100
| – | – |
|
|
PPGHU
2569
DELISTED
Poema Global Holdings Corp. Unit
PPGHU
| $6.29M | ﹤0.01% |
610,000
| – | – |
|
2570
Fluor
FLR
$7.12B
| $6.28M | ﹤0.01% |
393,443
-290,830
| -43% | -$4.77M |
|
|
EJFA
2571
DELISTED
EJF Acquisition Corp. Class A Ordinary Share
EJFA
| $6.28M | ﹤0.01% |
636,392
+240,238
| +61% | +$2.34M |
|
2572
Kemper
KMPR
$1.65B
| $6.27M | ﹤0.01% |
93,857
-37,119
| -28% | -$2.52M |
|
|
TWNI
2573
DELISTED
Tailwind International Acquisition Corp.
TWNI
| $6.25M | ﹤0.01% |
644,065
+508,346
| +375% | +$4.92M |
|
2574
Grid Dynamics Holdings
GDYN
$647M
| $6.24M | ﹤0.01% |
213,405
+194,955
| +1,057% | +$4.77M |
|
2575
Covenant Logistics
CVLG
$888M
| $6.24M | ﹤0.01% |
451,020
+370,886
| +463% | +$4.15M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.